- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-6-6-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-MAN.2: 6 residues within 4Å:- Chain A: N.165, T.167, R.207
- Chain E: S.219, P.221, W.222
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:W.222
NAG-NAG-BMA-MAN.5: 5 residues within 4Å:- Chain A: S.219, P.221, W.222
- Chain C: N.165, T.167
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:W.222
- Hydrophobic interactions: C:T.167
NAG-NAG-BMA-MAN.7: 5 residues within 4Å:- Chain C: S.219, P.221, W.222
- Chain E: N.165, T.167
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:W.222
NAG-NAG-BMA-MAN.18: 6 residues within 4Å:- Chain G: N.165, T.167, R.207
- Chain K: S.219, P.221, W.222
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:W.222
NAG-NAG-BMA-MAN.21: 5 residues within 4Å:- Chain G: S.219, P.221, W.222
- Chain I: N.165, T.167
2 PLIP interactions:1 interactions with chain I, 1 interactions with chain G- Hydrophobic interactions: I:T.167
- Hydrogen bonds: G:W.222
NAG-NAG-BMA-MAN.23: 5 residues within 4Å:- Chain I: S.219, P.221, W.222
- Chain K: N.165, T.167
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:W.222
- 4 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose(Non-covalent)
GAL-SIA.4: 11 residues within 4Å:- Chain A: Y.98, G.134, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.153, A:T.155
- Hydrogen bonds: A:Y.98, A:G.135, A:S.137, A:E.190, A:Q.226
GAL-SIA.6: 11 residues within 4Å:- Chain C: Y.98, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226, G.228
10 PLIP interactions:10 interactions with chain C- Hydrogen bonds: C:Q.226, C:Y.98, C:G.135, C:S.136, C:S.136, C:S.137, C:E.190, C:Q.226, C:G.228
- Hydrophobic interactions: C:W.153, C:T.155
GAL-SIA.20: 11 residues within 4Å:- Chain G: Y.98, G.134, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226
6 PLIP interactions:6 interactions with chain G- Hydrophobic interactions: G:W.153, G:T.155
- Hydrogen bonds: G:G.135, G:S.137, G:E.190, G:Q.226
GAL-SIA.22: 11 residues within 4Å:- Chain I: Y.98, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226, G.228
9 PLIP interactions:9 interactions with chain I- Hydrogen bonds: I:Q.226, I:G.135, I:S.136, I:S.136, I:S.137, I:E.190, I:Q.226, I:G.228
- Hydrophobic interactions: I:W.153, I:T.155
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 3 residues within 4Å:- Chain A: N.38, T.318
- Chain B: L.52
Ligand excluded by PLIPNAG.9: 5 residues within 4Å:- Chain B: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain C: N.38, T.318
- Chain D: L.52
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain C: N.81, F.120, I.121
Ligand excluded by PLIPNAG.12: 5 residues within 4Å:- Chain D: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain E: T.24, N.38, A.39
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain E: Q.80, N.81, E.119, F.120
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain E: N.285, V.297, N.298
- Chain F: E.69
Ligand excluded by PLIPNAG.16: 5 residues within 4Å:- Chain F: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain G: N.38, T.318
- Chain H: L.52
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain H: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain I: N.38, T.318
- Chain J: L.52
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain I: N.81, F.120, I.121
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain J: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain K: T.24, N.38, A.39
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain K: Q.80, N.81, E.119, F.120
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain K: N.285, V.297, N.298
- Chain L: E.69
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain L: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ha, Y. et al., X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology (2003)
- Release Date
- 2003-08-26
- Peptides
- Hemagglutinin HA1 chain: ACEGIK
Hemagglutinin HA2 chain: BDFHJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
DE
GG
AI
DK
GB
BD
EF
HH
BJ
EL
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-6-6-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose(Non-covalent)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ha, Y. et al., X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology (2003)
- Release Date
- 2003-08-26
- Peptides
- Hemagglutinin HA1 chain: ACEGIK
Hemagglutinin HA2 chain: BDFHJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
DE
GG
AI
DK
GB
BD
EF
HH
BJ
EL
H